Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex

Sung Ho Chen, Jen Kun Lin, Yu Chih Liang, Min Hsiung Pan, Shing Hwa Liu, Shoei Yn Lin-Shiau

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.

Original languageEnglish
Pages (from-to)9-17
Number of pages9
JournalEuropean Journal of Pharmacology
Volume594
Issue number1-3
DOIs
Publication statusPublished - Oct 10 2008
Externally publishedYes

Fingerprint

Activating Transcription Factors
Transcription Factor AP-1
Apoptosis
Chelating Agents
Caspase 3
Mitochondrial Membrane Potential
Poisons
HL-60 Cells
Cytochromes c
pyrrolidine dithiocarbamic acid
Sulfhydryl Compounds
Ascorbic Acid
Copper
Cultured Cells
Reactive Oxygen Species
Oxidative Stress
Phosphotransferases
Metals
DNA

Keywords

  • AP-1
  • Apoptosis
  • BCPS
  • Caspase
  • Copper
  • JNK
  • NF-κB
  • Oxidative stress
  • PDTC

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex. / Chen, Sung Ho; Lin, Jen Kun; Liang, Yu Chih; Pan, Min Hsiung; Liu, Shing Hwa; Lin-Shiau, Shoei Yn.

In: European Journal of Pharmacology, Vol. 594, No. 1-3, 10.10.2008, p. 9-17.

Research output: Contribution to journalArticle

Chen, Sung Ho ; Lin, Jen Kun ; Liang, Yu Chih ; Pan, Min Hsiung ; Liu, Shing Hwa ; Lin-Shiau, Shoei Yn. / Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex. In: European Journal of Pharmacology. 2008 ; Vol. 594, No. 1-3. pp. 9-17.
@article{a24c3e9b731b48d59e218f3d2324e17e,
title = "Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex",
abstract = "Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.",
keywords = "AP-1, Apoptosis, BCPS, Caspase, Copper, JNK, NF-κB, Oxidative stress, PDTC",
author = "Chen, {Sung Ho} and Lin, {Jen Kun} and Liang, {Yu Chih} and Pan, {Min Hsiung} and Liu, {Shing Hwa} and Lin-Shiau, {Shoei Yn}",
year = "2008",
month = "10",
day = "10",
doi = "10.1016/j.ejphar.2008.07.024",
language = "English",
volume = "594",
pages = "9--17",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex

AU - Chen, Sung Ho

AU - Lin, Jen Kun

AU - Liang, Yu Chih

AU - Pan, Min Hsiung

AU - Liu, Shing Hwa

AU - Lin-Shiau, Shoei Yn

PY - 2008/10/10

Y1 - 2008/10/10

N2 - Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.

AB - Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.

KW - AP-1

KW - Apoptosis

KW - BCPS

KW - Caspase

KW - Copper

KW - JNK

KW - NF-κB

KW - Oxidative stress

KW - PDTC

UR - http://www.scopus.com/inward/record.url?scp=50549096389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50549096389&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.07.024

DO - 10.1016/j.ejphar.2008.07.024

M3 - Article

C2 - 18671963

AN - SCOPUS:50549096389

VL - 594

SP - 9

EP - 17

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -